Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis

World Journal of Gastroenterology

Volumn 12, Issue 10, 2006, Pages 1617-1620

  Yamamoto Furusho, Jesus K ^a   Uscanga Domínguez, Luis ^a   Lopez Martinez, Alondra ^a   Granados, Julio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

HLA DR; Mexicans; p ANCA; Ulcerative colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; HLA DR ANTIGEN; HLA DR7 ANTIGEN; MERCAPTOPURINE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ALLELE; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; COLON BIOPSY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; HLA TYPING; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; PROCTOCOLECTOMY; ULCERATIVE COLITIS;

EID: 33645750268     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i10.1617     Document Type: Article

References (25)

1. Saxon A, Shanahan, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202-210
2. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100: 1590-1596
3. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100: 1590-1596
4. Yang H, Rotter JI. Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F eds. Inflammatory bowel disease: from bench to bedside. Baltimore, MD: Williams and Wilkins, 1994: 32-64.
5. Yamamoto-Furusho JK. Immunogenetics of chronic ulcerative colitis. Rev Invest Clin 2003; 55: 705-710
6. Satsangi J, Landers CJ, Welsh KI, Koss K, Targan S, Jewell DP. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm Bowel Dis 1998; 4:18-26
7. Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di Giorgio G, Andriulli A. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol 1998; 30: 56-61
8. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcon G, Ruiz-Morales JA, Higuera L, Cutino T, Rodriguez-Perez JM, Villarreal-Garza C, Granados J. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol 2003; 64:119-123
9. Lee YT, Sung JJ, Poon P, Lai KN, Li PK. Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33: 623-627
10. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis, and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995; 108: 423-427
11. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955; 1041-1048
12. Bekker-Mendez C, Yamamoto-Furusho JK, Vargas-Alarcon G, Ize-Ludlow D, Alcocer-Varela J, Granados J. Haplotype distribution of class II MHC genes in Mexican patients with systemic hipus erythematosus. Scand J Rheumatol 1998; 27: 373-376
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
14. Charron: Genetic diversity of HLA functional and medical implication. Proceeding of the 12th International Histocompatibility Workshop and Conference 1997. Paris, France. EDK, Medical and Scientific International Publisher, 1997.
15. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl 1989; 6: 12-13
16. Ludemann J, Utecht B, Gross WL. Detection and quantitation of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis by ELISA using affinity purified antigen. J Immunol Methods 1988; 114: 167-174
17. Yang H, Rotter JI, Toyoda H, Landers C, Tyran D, McElree CK, Targan SR. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993; 92:1080-1084
18. Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, Rink L. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol 1999; 34: 1025-1032
19. Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di Giorgio G, Andriulli A. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol 1998; 30: 56-61
20. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995; 108: 423-7
21. Heresbach D, Alizadeh M, Reumaux D, Colombel JF, Delamaire M, Danze PM, Gosselin M, Genetet B, Bretagne JF, Semana G. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? J Autoimmun 1996; 9: 777-784
22. Myung SJ, Yang SK, Jung HY, Chang HS, Park B, Hong WS, Kim JH, Min I. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int J Colorectal Dis 2002; 17: 233-237
23. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcon G, Rodriguez-Perez JM, Zuniga J, Granados J. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett 2004; 95: 31-35
24. Vargas-Alarcon G, Yamamoto-Furusho JK, Zuniga J, Canoso R, Granados J. HLA-DR7 in association with chlorpromazine-induced lupus anticoagulant (LA). J Autoimmun 1997; 10: 579-583
25. Granados J, Vargas-Alarcon G, Drenkard C, Andrade F, Melin-Aldana H, Alcocer-Varela J, Alarcon-Segovia D. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Lupus 1997; 6: 57-62